AI-Assisted vs Usual Follow-up in Kidney Transplantation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 140
- 试验地点
- 1
- 主要终点
- Consultation quality measured by the MAAS-Global global score
研究概览
简要总结
The goal of this clinical trial is to learn whether kidney transplant follow-up visits run by a health professional using an artificial intelligence (AI) computer helper are as good as usual follow-up visits with a doctor.
People who receive a kidney transplant need check-up visits for the rest of their lives. These visits help keep the new kidney working well. As more people live longer with a transplant, clinics get busier. An AI helper may make visits more consistent and free up doctor time. This idea has not yet been tested well in real clinics.
The main questions this study will answer are:
Are AI-assisted visits as good as usual doctor visits? Trained reviewers will rate the quality of each visit. The reviewers will not know which type of visit they are rating.
Are patients as satisfied with their visit? How long does the visit take, and how much time does the clinician spend on paperwork? Do the visits do a better job of checking key items, such as screening tests, vaccines, and transplant medicines? Are the visits safe for patients?
Adults can take part if they have a working kidney transplant, if the transplant was at least 6 months ago, and if they can complete a routine visit on their own.
Researchers will place 140 adults into two groups by chance, like flipping a coin. One group will have a visit run by a health professional who uses the AI helper. The other group will have a usual visit with a doctor. In both groups, the AI cannot order tests, change medicines, or make a diagnosis on its own. A clinician checks and approves everything.
Participants will take part in one study follow-up visit. The visit will be audio-recorded so reviewers can rate it later. After the visit, participants will fill out a short satisfaction survey on a tablet.
详细描述
Rationale. Kidney transplant recipients require lifelong, protocol-driven outpatient follow-up. After the first 6 to 12 months, care of stable recipients becomes standardized, and a large share of each routine visit is spent on standardizable tasks: laboratory review, immunosuppression reconciliation, screening and vaccination checks, and clinical documentation. Growing recipient numbers, a shortage of nephrologists, and the concentration of specialists in tertiary centers lengthen follow-up intervals, particularly within the Brazilian Unified Health System (SUS). Large language models (LLMs) have shown promise on patient-facing tasks, but existing evidence derives mainly from vignette- or forum-based comparisons, without real-workflow evaluation, prospective safety endpoints, or blinded quality instruments. A retrieval-augmented generation (RAG) architecture that grounds model outputs in an indexed base of guidelines and institutional protocols, with verifiable citations and explicit uncertainty flagging, addresses hallucination risk and enables auditable, specialty-specific use. This trial moves the evaluation of LLM support from vignettes to a real ambulatory workflow under mandatory human supervision.
Study design and setting. This is a randomized, controlled, parallel-group, non-inferiority trial conducted at the kidney transplant outpatient clinic of the Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Brazil. Reporting follows the CONSORT 2010 statement. Allocation is 1:1 to an AI-assisted follow-up consultation or a usual physician-led consultation.
Intervention (AI-assisted arm). A trained health professional conducts the routine follow-up consultation while a specialized LLM assistant provides real-time support. The assistant is built on a general-purpose LLM adapted for clinical dialogue and operates through a RAG pipeline that indexes KDIGO guidelines and clinic standard operating procedures. During the encounter the assistant supplies a structured content checklist, guideline-anchored suggestions with source citations, uncertainty flags, and a draft structured clinical note and orders. Guardrails prevent the assistant from finalizing medication changes, orders, or diagnoses. Every proposed action is flagged for clinician review; the responsible clinician verifies vital signs and findings, corrects inaccuracies, and co-signs the encounter before any action is enacted (human-in-the-loop). Transcripts and structured data are stored in the electronic data capture system.
Comparator (usual-care arm). Standard physician-led transplant follow-up per routine clinic practice and current guidelines, comprising history, medication reconciliation with a focus on immunosuppression, focused examination, and management plan.
To limit performance bias, both arms follow an identical pre-specified content checklist and target a similar consultation duration. All consultations are audio-recorded to permit later blinded assessment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18 years or older
- •Have a working kidney transplant
- •Received the kidney transplant at least 6 months ago
- •Able to take part in a routine follow-up visit on their own
- •Able to understand the study and give informed consent
排除标准
- •Have a sudden or serious illness that needs urgent care
- •Have a thinking or sensory problem that means they need another person's help during the visit
- •Cannot communicate in Portuguese, the language used in the study
- •Are taking part in another study that would conflict with this one
研究组 & 干预措施
AI-Assisted Follow-up Consultation
In this arm, a trained health professional conducts the routine follow-up consultation while a specialized large language model (LLM) assistant provides real-time support. The assistant uses a retrieval-augmented generation (RAG) pipeline indexed on KDIGO guidelines and clinic standard operating procedures, and supplies a structured content checklist, guideline-anchored suggestions with source citations, uncertainty flags, and a draft structured clinical note and orders. Guardrails prevent the assistant from finalizing medication changes, orders, or diagnoses. The responsible clinician reviews and verifies all findings, corrects inaccuracies, and approves and co-signs the encounter before any action is enacted (human-in-the-loop). The consultation follows a pre-specified content checklist and is audio-recorded for later blinded quality assessment.
干预措施: AI-Assisted Follow-up Consultation (Other)
Usual Physician-Led Follow-up
In this arm, participants receive standard physician-led kidney transplant follow-up according to routine clinic practice and current guidelines, without the AI assistant. The consultation comprises history-taking, medication reconciliation with a focus on immunosuppression, focused examination, and a management plan. The consultation follows the same pre-specified content checklist and targets a similar duration to the AI-assisted arm, and is audio-recorded for later blinded quality assessment.
干预措施: Usual Physician-Led Follow-up Consultation (Other)
结局指标
主要结局
Consultation quality measured by the MAAS-Global global score
时间窗: Consultation quality measured at Day 1
Overall quality of the follow-up consultation, scored with the MAAS-Global instrument, a validated tool for rating clinician consultation skills. Consultation quality is reported as the MAAS-Global global score, which ranges from 0 to 6, where 0 indicates the poorest consultation quality and 6 indicates the highest consultation quality (higher scores indicate better quality). Consultations are audio-recorded and scored by trained raters who are blinded to group allocation. This is the primary endpoint for the non-inferiority comparison between the AI-assisted consultation and the usual physician-led consultation.
次要结局
- Patient satisfaction measured by the VSQ-9(Patient satisfaction at day 1)
